Amesite Announces NurseMagic™ Enterprise Contract Wins in High Growth Companies with Hundreds of Franchise Owners
DETROIT, Dec. 18, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), creator of the NurseMagic™ app, has closed on contracts […]
LeddarTech Reports FY24 Results
QUEBEC CITY, Canada, Dec. 18, 2024 (GLOBE NEWSWIRE) — LeddarTech® Holdings Inc. (“LeddarTech”) (Nasdaq: LDTC), an automotive software company that […]
Novacium’s Silicon-Anode Batteries Show Superior Cumulative Energy Return Over 650 Cycles—Compared to High-Grade Artificial Graphite
18650 batteries with GEN3 silicon-anode materials demonstrate a 30% cumulative energy return compared to graphite benchmark batteries during and up […]
Draganfly Completes First Proof-of-Concept Flights in Drone Delivery Research Project for Mass General Brigham
Draganfly’s medical drone delivery infrastructure offers new model for future improvement in service time for Home Hospital care Boston, MA., […]
Microchip Adds MTCH2120 to its Portfolio of Turnkey Capacitive Touch Controllers
CHANDLER, Ariz., Dec. 18, 2024 (GLOBE NEWSWIRE) — Turnkey touch controllers are a fast and easy way to upgrade from […]
Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions
– $150 Million Senior Secured Term Loan Credit Facility and New $100 Million Convertible Note to Repay Significant Portion of […]
TSX News -
CMG to Participate in the 27th Annual Needham Growth Conference
CALGARY, Alberta, Dec. 18, 2024 (GLOBE NEWSWIRE) — Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) is pleased […]
TSX News -
Probe Gold to Acquire the Stella Property in Val-d’Or, Quebec
Highlights: Strategic Acquisition: The Stella Property hosts the high-grade Lacoma gold zone discovered in 1925 and is strategically located between […]
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)
MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel […]
Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform […]
